GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (OTCPK:FFNTF) » Definitions » Cyclically Adjusted PB Ratio

4Front Ventures (4Front Ventures) Cyclically Adjusted PB Ratio : (As of Apr. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is 4Front Ventures Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


4Front Ventures Cyclically Adjusted PB Ratio Historical Data

The historical data trend for 4Front Ventures's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures Cyclically Adjusted PB Ratio Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

4Front Ventures Quarterly Data
Jan19 Apr19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of 4Front Ventures's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Cyclically Adjusted PB Ratio falls into.



4Front Ventures Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

4Front Ventures's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, 4Front Ventures's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.077/129.4194*129.4194
=-0.077

Current CPI (Dec. 2023) = 129.4194.

4Front Ventures Quarterly Data

Book Value per Share CPI Adj_Book
201401 -0.113 98.692 -0.148
201404 -1.318 100.023 -1.705
201407 -1.412 100.520 -1.818
201410 -1.671 100.176 -2.159
201501 -1.247 98.604 -1.637
201504 -1.555 99.824 -2.016
201507 -0.390 100.691 -0.501
201510 -0.432 100.346 -0.557
201601 -0.446 99.957 -0.577
201604 -0.180 100.947 -0.231
201607 -0.188 101.524 -0.240
201610 -0.114 101.988 -0.145
201701 -0.245 102.456 -0.309
201704 -0.276 103.167 -0.346
201707 -0.311 103.278 -0.390
201710 -0.309 104.070 -0.384
201801 -0.321 104.578 -0.397
201804 0.169 105.708 0.207
201807 0.184 106.324 0.224
201810 0.189 106.695 0.229
201901 0.191 106.200 0.233
201904 -0.054 107.818 -0.065
201909 0.451 108.329 0.539
201912 0.141 108.420 0.168
202003 0.132 108.902 0.157
202006 0.128 108.767 0.152
202009 0.125 109.815 0.147
202012 0.079 109.897 0.093
202103 0.075 111.754 0.087
202106 0.090 114.631 0.102
202109 0.087 115.734 0.097
202112 0.063 117.630 0.069
202203 0.085 121.301 0.091
202206 0.086 125.017 0.089
202209 0.077 125.227 0.080
202212 0.044 125.222 0.045
202303 0.028 127.348 0.028
202306 0.012 128.729 0.012
202309 -0.077 129.860 -0.077
202312 -0.077 129.419 -0.077

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


4Front Ventures  (OTCPK:FFNTF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


4Front Ventures Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


4Front Ventures (4Front Ventures) Business Description

Traded in Other Exchanges
Address
5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
Executives
Leonid Gontmakher director, officer: Chief Executive Officer 5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Nicole Frederick officer: See Remarks C/O 4FRONT VENTURES CORP., 7010 E. CHAUNCEY LANE STE. 235, PHOENIX AZ 85054
Kristopher Krane director 5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
David Ryan Daily director 5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Roman Tkachenko director 5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Karl Chowscano other: Consultant 5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Chetan Gulati director 28 REICHERT CIRCLE, WESTPORT CT 06880
Keith Edward Adams officer: Chief Financial Officer 108 S. WETHERLY DRIVE, UNIT 4, LOS ANGELES CA 90048
Robert E Hunt director C/O GROWLIFE, INC., 20301 VENTURA BLVD., SUITE 126, WOODLAND HILLS CA 91364
Amit Ramanlal Patel director 3305 PINE AVENUE, MANHATTAN BEACH CA 90266
Kathi P Lentzsch director 5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Andrew Thut officer: Chief Investment Officer 5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Joseph R Feltham officer: Chief Operating Officer 5060 N. 40TH STREET, STE 120, PHOENIX AZ 85018
Eric J. Rey director ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Nicolle Dorsey officer: Chief Financial Officer C/O REAL GOODS SOLAR, INC., 110 16TH STREET, 3RD FLOOR, DENVER CO 80202